News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
267,602 Results
Type
Article (14224)
Company Profile (108)
Press Release (253270)
Section
Business (89320)
Career Advice (547)
Deals (15502)
Drug Delivery (64)
Drug Development (37675)
Employer Resources (51)
FDA (6347)
Job Trends (6312)
News (152551)
Policy (14200)
Tag
Academia (546)
Alliances (23435)
Alzheimer's disease (752)
Approvals (6357)
Artificial intelligence (66)
Bankruptcy (145)
Best Places to Work (4460)
Biotechnology (45)
Breast cancer (61)
Cancer (418)
Career advice (477)
Cell therapy (58)
Clinical research (31212)
Collaboration (201)
Compensation (83)
COVID-19 (775)
C-suite (59)
Data (454)
Diabetes (66)
Diagnostics (1308)
Drug discovery (43)
Drug pricing (60)
Earnings (31999)
Employer resources (48)
Events (37820)
Executive appointments (221)
FDA (6594)
Funding (138)
Gene therapy (65)
GLP-1 (309)
Government (1311)
Healthcare (3801)
Infectious disease (795)
Inflammatory bowel disease (49)
Interviews (73)
IPO (5916)
Job creations (2068)
Job search strategy (428)
Layoffs (175)
Legal (3455)
Lung cancer (60)
Manufacturing (111)
Medical device (1326)
Medtech (1328)
Mergers & acquisitions (9664)
Metabolic disorders (195)
Neuroscience (878)
NextGen Class of 2024 (1668)
Non-profit (693)
Northern California (515)
Obesity (113)
Opinion (119)
Patents (66)
People (29094)
Pharmaceutical (67)
Phase I (8158)
Phase II (13287)
Phase III (11797)
Pipeline (200)
Policy (48)
Postmarket research (1407)
Preclinical (3289)
Radiopharmaceuticals (120)
Rare diseases (111)
Real estate (2665)
Regulatory (10010)
Research institute (637)
Resumes & cover letters (72)
Southern California (495)
Startups (1644)
United States (5081)
Vaccines (125)
Weight loss (84)
Date
Last 7 days (61)
Last 30 days (592)
Last 365 days (12665)
2025 (34)
2024 (12937)
2023 (14650)
2022 (20024)
2021 (20598)
2020 (19495)
2019 (15392)
2018 (12049)
2017 (14152)
2016 (13385)
2015 (15759)
2014 (12697)
2013 (10804)
2012 (11595)
2011 (12109)
2010 (11010)
Location
Africa (329)
Asia (20177)
Australia (2647)
California (1194)
Canada (683)
China (151)
Colorado (46)
Connecticut (49)
Europe (39503)
Florida (196)
Illinois (137)
Indiana (98)
Japan (58)
Kansas (53)
Maryland (177)
Massachusetts (1038)
Minnesota (65)
New Jersey (511)
New York (378)
North Carolina (299)
Northern California (515)
Pennsylvania (342)
South America (518)
Southern California (495)
Texas (163)
Virginia (46)
Washington State (87)
267,602 Results for "sigma tau pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Sponsored
SignalChem’s Tau Proteins: Accelerating Neurodegenerative Disease Research
SignalChem Biotech provides diverse recombinant Tau proteins for research, helping advance tau-targeted therapies that may modify disease progression in Alzheimer’s and related tauopathies.
November 18, 2024
·
3 min read
Drug Development
Late-Stage Alzheimer’s Pipeline Goes Beyond Amyloid and Tau
The next generation of Alzheimer’s therapeutics is moving away from amyloid plaques and tau tangles, offering multiple approaches to slow cognitive decline.
September 9, 2024
·
6 min read
·
Gail Dutton
Press Releases
Veravas Completes Analytical Verification Study of the VeraBIND Tau Assay, a Groundbreaking Test to Measure Alzheimer’s Tau Pathology in Blood
November 20, 2024
·
6 min read
Press Releases
Alpha Tau to Participate in Ladenburg’s Oncology Innovators & Investors Symposium
December 6, 2024
·
1 min read
Press Releases
Alpha Tau to Present at the 43rd Annual J.P. Morgan Healthcare Conference
December 11, 2024
·
1 min read
Alpha Tau to Present at the Jefferies Global Healthcare Conference
Alpha Tau Medical Ltd. today announced that CFO Raphi Levy will present a corporate overview and update at the Jefferies Global Healthcare Conference on June 5 th , 2024.
May 21, 2024
·
1 min read
Alpha Tau to Participate in May 2024 Investor Conferences
Alpha Tau Medical Ltd., the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, announced that CFO Raphi Levy will present at the following investor conferences in May 2024.
May 1, 2024
·
1 min read
Press Releases
Voyager Selects Tau Silencing Gene Therapy Development Candidate for Alzheimer’s Disease
November 20, 2024
·
7 min read
Drug Development
Voyager Therapeutics Announces First Participants Dosed in Single Ascending Dose Trial of VY-TAU01 for the Treatment of Alzheimer’s Disease
Voyager Therapeutics, Inc. today announced that the first participants were dosed in a Phase 1a single ascending dose (SAD) trial of VY-TAU01, an investigational anti-tau antibody developed to inhibit the spread of pathological tau in Alzheimer’s disease.
May 16, 2024
·
6 min read
Press Releases
Alpha Tau Announces Upcoming Presentation of New Data at 2025 ASCO GI Symposium and at Company R&D Update Day
December 18, 2024
·
5 min read
1 of 26,761
Next
